Related Experiment Video
Updated: Jul 11, 2026

Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems
Published on: April 23, 2012
Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule:
Thomas Hammerschmidt1, Helmtrud Bisanz, Peter Wutzler
1GlaxoSmithKline, Theresienhoehe 11, D-80339 Munich, Germany. thomas.hammerschmidt@gsk.com
Abstract:
Former economic analyses have shown that universal mass vaccination of infants against varicella using a one-dose schedule is cost-saving in Germany. In July 2006, an MMRV combination vaccine has been approved in Germany which shall be given in a two-dose schedule. We re-analysed our former analysis with the EVITA model in order to prove whether our former conclusion that universal mass vaccination against varicella is cost-saving is still valid when using a two-dose schedule vaccine. Indeed we found that universal mass vaccination of infants against varicella with a two-dose vaccine is cost-saving from societal as well as from health care perspective.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
Related Concept Videos
Vaccinations
Vaccines
Chickenpox
Smallpox
Vaccine Production
Respiratory Syncytial Virus Disease